from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3357/relJ

LFCtreatmentdescriptionclass of inhibitor

0.889

Amikacinug/mL Amikacintranslation

1.412

Cap5-10ug/mL Capreomycintranslation

1.773

Rox10-50 ug/mL Roxithromycintranslation

0.232

SM2-5 ug/mL Streptomycintranslation

2.386

Tet5-10 ug/mL Tetracyclinetranslation

0.405

Rif0.2-5ug/mL Rifampicintranscription

-0.222

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.948

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.541

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.069

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.466

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.434

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.481

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.759

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.348

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.441

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.077

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.426

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.736

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.488

KCN5-20 ug/mL Potassium cyaniderespiration

-1.388

NaN30.2-2 mM Sodium aziderespiration

-0.214

Nigericin50 uM Nigericinrespiration

0.897

TRC10-150 ug/mL Triclosanrespiration

0.164

TRZ10-25 ug/mL Thioridazinerespiration

4.156

Valinomycin0.5-10 uM Valinomycinrespiration

1.461

ZnSO42 mM ZnSO4respiration

-0.312

menadione6-10 ug/mL Menadionerespiration

-0.254

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.069

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.121

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.160

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.567

NRP_1Non-replicating persistence stage 1dosRassociated

-0.424

Amp0.2mg/mL AmpicillincellWall

-0.228

Cephalexin20-100 ug/mL CephalexincellWall

0.192

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.082

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.165

EMB10-20 ug/mL EthambutolcellWall

-0.298

Eta12-40 ug/mL EthionamidecellWall

-0.567

INH0.2-0.4 ug/mL IsoniazidcellWall

0.147

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.663

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.564

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.281

BZA0.12 mg/mL BenzamidearomaticAmides

0.091

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.259

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.382

H2O24 mM hydrogen peroxideDNAdamaging

0.084

Levo10 ug/mL LevofloxacinDNAdamaging

-0.527

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.793

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.270

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.000

UVUV-irradiationDNAdamaging

-2.465

ARP41-4 ug/mL Antitubercular compound ARP4?

0.113

Antimycin12.5-50 ug/mL Antimycin A?

0.534

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.399

PA_110-50 ug/mL Antitubercular compound PA-1?

0.033

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.313

PA8240.2-2 ug/mL PA-824?

-0.619

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.699

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.354

Verapamil50 uM Verapamil?

0.615

mercaptoethanol2 mM 2-Mercaptoethanol?

0.107

methoxatin10-20 ug/mL Methoxatin?